Farrah Pompilus
Farrah Pompilus publishes mostly in Hematology, Oncology and Surgery, on topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors and Acute Myeloid Leukemia Research.
- World rank
- #2,696,397 of 7,710,434 ranked researchers
- Rank in United States
- #786,692 of 1,627,098
- Works
- 49
- Citations
- 771
- Citations per work
- 15.7
What does Farrah Pompilus research?
Farrah Pompilus's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (10%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2347.5%
- Medicine2347.5%
- Everything else1836.4%
- Life Sciences510.2%
- Social Sciences35.9%
- 1Hematology15% of their works
- 2Oncology14% of their works
- 3Surgery10% of their works
- 4Molecular Biology10% of their works
- 5Pulmonary and Respiratory Medicine8% of their works
- 6Economics and Econometrics6% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Protein Degradation and Inhibitors
- Acute Myeloid Leukemia Research
- Cancer Treatment and Pharmacology
- Health Systems, Economic Evaluations, Quality of Life
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cancer survivorship and care
- Peptidase Inhibition and Analysis
Which keywords describe Farrah Pompilus's research?
The keywords of their largest research topics: Quality of Life, Diagnosis Criteria, International Myeloma Working Group, Acute Myeloid Leukemia, AML, BET Bromodomains, PROTACs and Chemotherapy-Induced Peripheral Neuropathy.
- Fibroblast Activation Protein
- Myelofibrosis
- Cancer Survivorship
- Health Utility Measures
- Chemotherapy-Induced Peripheral Neuropathy
- BET Bromodomains
- AML
- Diagnosis Criteria
- Quality of Life
- International Myeloma Working Group
- Acute Myeloid Leukemia
- PROTACs
- Cost-effectiveness Analysis
- Taxanes
- JAK2 Mutation
- Patient-Reported Outcomes
- Tumor Microenvironment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Quality of Life143 topics
- Diagnosis Criteria111 topic
- International Myeloma Working Group111 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- BET Bromodomains61 topic
- PROTACs61 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Cost-effectiveness Analysis51 topic
- Health Utility Measures51 topic
- Taxanes51 topic
- Cancer Survivorship41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Patient-Reported Outcomes41 topic
- Fibroblast Activation Protein31 topic
- Tumor Microenvironment31 topic
Where does Farrah Pompilus work?
Farrah Pompilus's main affiliation in the publication record is Adelphi Laboratory Center, United States.
How many publications and citations does Farrah Pompilus have?
OpenAlex counts 49 works and 771 citations for Farrah Pompilus, an h-index of 10, ranking #2,696,397 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Farrah Pompilus. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.